摘要
目的:观察人结直肠癌组织和细胞株中ATPaseF1α的表达,并探讨其意义。方法:应用免疫组化EnVision法测定收集自长海医院2007年8月至12月的44例结直肠癌组织及癌旁组织手术切除标本中ATPaseF1α的表达;半定量RT-PCR方法检测8例结直肠癌及癌旁组织中ATPaseF1αmRNA的表达水平。采用免疫荧光法检测ATPaseF1α在人结肠癌Lo-Vo细胞株胞膜的表达;采用CCK-8活细胞计数法检测抗ATPaseF1α抗体对LoVo细胞增殖的抑制作用。结果:44例结直肠癌组织中ATPaseF1α的表达显著高于癌旁组织(P<0.01);44例结直肠癌组织中ATPaseF1α的中高度表达有35例(79.5%),癌旁配对组织的中高度表达为15例(34.1%)。8例结直肠癌组织中ATPaseF1αmRNA的表达明显高于癌旁组织(P<0.01)。ATPaseF1α在结直肠癌组织中的阳性表达率高于患者术前血浆CEA阳性率(P<0.01),而与患者年龄、性别、肿瘤的临床分期、淋巴结转移、远处转移、肿瘤的部位、分化程度等均无关(P>0.05)。结肠癌LoVo细胞株胞膜上可见颗粒状分布的ATPaseF1α,ATPaseF1α抗体对LoVo细胞的增殖活性有明显的抑制作用(P<0.01)。结论:人结直肠癌组织和细胞株均高表达ATPaseF1α,其作为肿瘤抗原,有可能成为结直肠癌靶向治疗的新靶点。
Objective: To observe the expression of ATPase F1α in colorectal cancer (CRC) tissues and in LoVo cells, and to discuss its clinical significance. Methods: Expression of ATPase F1α protein in 64 CRC specimens and their adjacent normal tissues (August 2007 to December 2007, Changhai Hospital) and ATPase F1α mRNA in 8 colorectal cancer tissues and their adjacent normal tissues were examined by immunohistochemistry EnVision assay and RT-PCR, respectively. Expression of ATPase F1α on the cell surface of LoVo cells was observed by immunofluorescence. The inhib- itory effect of anti-ATPase F1α antibody on the proliferation of LoVo cells was evaluated by CCK-8 assay. Results: Ex- pression of ATPase F1α in the 44 CRCs were significantly higher than those in the adjacent normal tissues as detected by immunohistoehemistry (P 〈0.01 ). Thirty-five samples (79.5%) in 44 CRCs and 15 samples (34.1%) in their adja- cent normal tissues showed moderate to high expression of ATPase F1α. Expression of ATPase F1α mRNA in 8 CRCs was significantly higher than those in their adjacent normal tissues (P 〈 0.01 ). Positive rate of ATPase F1α mRNA in CRCs was significantly higher than that of CEA in the same patients before surgery (P 〈 0.01 ). There was no correlation of AT- Pase F1α expression with the age, gender, tumor stage, lymphoid metastasis, remote metastasis, tumor location and tumor differentiation of colorectal cancer ( P 〉 0.05 ). Expression of ATPase F1α was observed on the cell surface of LoVo cells, and anti-ATPase F1α antibody significantly inhibited the proliferation of LoVo cells (P 〈 0.01 ). Conclusion: ATPase F1α is highly expressed in colorectal cancer tissues and cell line. As a tumor association antigen, ATPase F1α may serve as a new target in colorectal cancer immunotherapy.
出处
《中国肿瘤生物治疗杂志》
CAS
CSCD
北大核心
2009年第2期181-186,共6页
Chinese Journal of Cancer Biotherapy
基金
全军医学科研"十一五计划"资助项目(No.01MA159)~~